MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Variants in the beta-Glucocerebrosidase A (GBA) gene in German patients with Parkinson´s disease

A. Deutschlander, A. Wernick, R. Walton, A. Soto, O. Ross, Z. Wszolek (Jacksonville, FL, USA)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Vortioxetine treatment of depression in Parkinson’s disease

M. Russo, C. Carrarini, F. Dono, L. Ferri, M. Di Pietro, M. Onofrj (Chieti, Italy)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting

A. Podlewska, D. van Wamelen, A. Sauerbier, V. Leta, D. Trivedi, M. Parry, K. Ray Chaudhuri (Lodnon, United Kingdom)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Wearable versus marker-free technologies: does it matter for clinical gait analysis?

K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
WES analysis of Parkinson’s disease patients with Cancer

Y. Gao, G. Wang, X. Xie (Shanghai, China)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
What connectivity tells us about neurodegeneration in Huntington disease? A fMRI study

P. de Azevedo, M. Nogueira, L. Ribeiro, B. de Campos, R. Guimarães, L. Piovesana, F. Cendes, I. Lopes-Cendes, C. Yasuda (Campinas, Brazil)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
What do medical students think about functional movement disorders?

JB. Paredes, E. Villalba, A. Canovas, JL. Sendon, P. Torre, S. Argos, S. Madrona, J. Poles, V. Hristova, L. García, JC. Castrillo, I. Moreno (Madrid, Spain)

Functional (Psychogenic) Movement Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease

R. Dano, JN. Petry-Schmelzer, J. Steffen, G. Fink, M. Barbe (Cologne, Germany)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Whole Exome Sequencing Identifies a Homozygous POLG2 Missense Variant in an adult patient presenting with movement disorders and Mitochondrial DNA Depletion

P. Dosekova, V. Habalova, M. Skirkova, V. Han, A. Mosejova, Z. Gdovinova, M. Skorvanek, R. Ploski (Kosice, Slovakia)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay

R. Valenti-Azcarate, I. Martinez-Valbuena, C. Caballero, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, M. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

Other  ·  Agora 2 West, Level 2
  • «Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley